Skip to main content
Clinical Trials/JPRN-UMIN000050757
JPRN-UMIN000050757
Not yet recruiting
未知

A multicenter Randomized Controlled trial of surgical treatment for congenital nasolacrimal duct obstruction. - A multicenter Randomized Controlled trial of surgical treatment for congenital nasolacrimal duct obstruction.

Japanese Society of Lacrimal Passage and Tear Dynamics0 sites408 target enrollmentApril 6, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
congenital nasolacrimal duct obstruction
Sponsor
Japanese Society of Lacrimal Passage and Tear Dynamics
Enrollment
408
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 6, 2023
End Date
May 10, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japanese Society of Lacrimal Passage and Tear Dynamics

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. patients with congenital malformation syndrome, developmental delay, facial deformity, or facial abnormality 2\. patients with perinatal abnormalities such as prematurity and low birth weight 3\. patients with other diseases such as keratitis, which cause epiphora and mucoid discharge and are difficult to distinguish 4\. patients with a history of surgery related to the lacrimal apparatus 5\. patients with a history of previous trauma to the eyelid or face that may cause damage to the lacrimal duct 6\. patients with a history of infection such as epidemic keratoconjunctivitis or eyelid herpes, which may cause abnormalities of the lacrimal duct 7\. patients with lacrimal punctum obstruction or lacrimal fistula 8\. patients with congenital dacryocele or acute dacryocystitis 9\. other patients whom the physician in charge determines to be difficult to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials